PHARMACEUTICAL NANOTECHNOLOGY BIOPHARMACEUTICAL SUPPORT IN CANDIDATE DRUG SELECTION

http://dx.doi.org/10.31703/gdddr.2018(III-I).05      10.31703/gdddr.2018(III-I).05      Published : Dec 2018
Authored by : Najam ul Hassan , Maria Naz Bakhtiari , Dur E Nayab

05 Pages : 31-35

References

  • Cu, Y., & Saltzman, W. M. (2009). Mathematical modeling of molecular diffusion through mucus. Adv Drug Deliv Rev, 61(2): 101-114
  • Lamont, J. T. (1992). Mucus: the front line of intestinal mucosal defense. Annals of the New York Academy of Sciences, 664(1): 190-201.
  • Harvey, A. L., Edrada-Ebel, R., & Quinn, R. J. (2015). The re-emergence of natural products for drug discovery in the genomics era. Nature Reviews Drug Discovery, 14(2), 111–129.
  • Eriksson L, Johansson E & Kettaneh-Wold N (1999): Multi- and Megavariate Data Analysis using Projection Methods (PCA & PLS). Umea, Sweden: Umetrics, 32(3): 231-242
  • Hunter J, Hirst BH. Intestinal secretion of drugs (1997): The role of P-glycoprotein and related drug efflux systems in limiting oral drug absorption. Adv Drug Deliv Rev, 25: 129–157.
  • Kuentz, M. (2011). Oral self-emulsifying drug delivery systems, from biopharmaceutical to technical formulation aspects. Journal of Drug Delivery Science and Technology, 21(1), 17–26.
  • O’Driscoll, C. M., & Griffin, B. T. (2008). Biopharmaceutical challenges associated with drugs with low aqueous solubility—The potential impact of lipid-based formulations. Advanced Drug Delivery Reviews, 60(6), 617– 624.
  • Yazdanian, M. (2013). Overview of determination of biopharmaceutical properties for Development Candidate selection. Current Protocols in Pharmacology, 60(1).

Cite this article

APA

    APA : Hassan, N. u., Bakhtiari, M. N., & Nayab, D. E. (2018). Pharmaceutical Nanotechnology: Bio-pharmaceutical Support in Candidate Drug Selection. Global Drug Design & Development Review, III(I), 31-35. https://doi.org/10.31703/gdddr.2018(III-I).05

CHICAGO

    CHICAGO : Hassan, Najam ul, Maria Naz Bakhtiari, and Dur E Nayab. 2018. "Pharmaceutical Nanotechnology: Bio-pharmaceutical Support in Candidate Drug Selection." Global Drug Design & Development Review, III (I): 31-35 doi: 10.31703/gdddr.2018(III-I).05

HARVARD

    HARVARD : HASSAN, N. U., BAKHTIARI, M. N. & NAYAB, D. E. 2018. Pharmaceutical Nanotechnology: Bio-pharmaceutical Support in Candidate Drug Selection. Global Drug Design & Development Review, III, 31-35.

MHRA

    MHRA : Hassan, Najam ul, Maria Naz Bakhtiari, and Dur E Nayab. 2018. "Pharmaceutical Nanotechnology: Bio-pharmaceutical Support in Candidate Drug Selection." Global Drug Design & Development Review, III: 31-35

MLA

    MLA : Hassan, Najam ul, Maria Naz Bakhtiari, and Dur E Nayab. "Pharmaceutical Nanotechnology: Bio-pharmaceutical Support in Candidate Drug Selection." Global Drug Design & Development Review, III.I (2018): 31-35 Print.

OXFORD

    OXFORD : Hassan, Najam ul, Bakhtiari, Maria Naz, and Nayab, Dur E (2018), "Pharmaceutical Nanotechnology: Bio-pharmaceutical Support in Candidate Drug Selection", Global Drug Design & Development Review, III (I), 31-35

TURABIAN

    TURABIAN : Hassan, Najam ul, Maria Naz Bakhtiari, and Dur E Nayab. "Pharmaceutical Nanotechnology: Bio-pharmaceutical Support in Candidate Drug Selection." Global Drug Design & Development Review III, no. I (2018): 31-35. https://doi.org/10.31703/gdddr.2018(III-I).05